Related Experiment Videos
Anaemia and agranulocytosis associated with ticlopidine therapy
Acta Haematologica
|January 1, 1985
Abstract:
Although ticlopidine has proven anti-aggregant properties, complications due to side-effects, particularly to the haemopoietic system, have been noted since it was recently launched on the market. We here report a case of bicytopenia (anaemia and granulocytopenia) associated with ticlopidine treatment.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Annals of hematology·2018
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab).
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Eltrombopag-induced serum pigmentation in severe aplastic anemia: a case report.
Acta haematologica·2026
Transforming Hemophilia Treatment With Novel Rebalancing Agents: Clinical Studies and Practical Perspectives.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Targeting Thrombopoietin/MPL Signaling to Mitigate JAK2V617F-Driven Cardiac Microvascular Disease.
Arteriosclerosis, thrombosis, and vascular biology·2026
Machine Learning-Based Prediction of Hemoglobin Variability in Patients with Chronic Kidney Disease Receiving Erythropoiesis-Stimulating Agents: A Real-World Retrospective Study.
International journal of nephrology and renovascular disease·2026